NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1124524863 MD
Verify on CMS → Michael Goldstein, MD
Endocrinology, Diabetes & Metabolism Physician in Mineola, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 496 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
32%
generic claims · 61% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$125
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Michael Goldstein, MD filed 2,719 Medicare Part D claims in 2024 as an Endocrinology, Diabetes & Metabolism Physician in Mineola, New York, prescribing 32% generic.
- 3K
- Part D claims, 2024
- 32%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥87th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Michael Goldstein, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1124524863), first enumerated 04/02/2018.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,719 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$125 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Michael Goldstein, MD's individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1124524863 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-RECENT · TAX-MID · RX-MID · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1124524863
- ENUM-RECENT 2018
- TAX-MID 8K Endocrinology, Diabetes
- RX-MID 2,719
- BOOK-LIGHT 813 in New York
- PHOTO-ENUM Rabail Soomro · 2018
Michael Goldstein, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
2,719 ≥ 87th percentile 87% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Michael Goldstein, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michael Goldstein, MD?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
2,719 1% vs specialty avg
Specialty distribution in New York
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New York providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1124524863 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 04/02/2018 |
Hospital and facility affiliations
Facilities where Michael Goldstein, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
New York University
New York, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Michael Goldstein, MD. Source: openpaymentsdata.cms.gov.
Total received
$125
Largest payer
Novo Nordisk Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Michael Goldstein, MD. To verify Michael Goldstein, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Michael Goldstein, MD - brand share 61.0%
Endocrinology, Diabetes & Metabolism Physician average
61% brand-name claims vs 32% generic, on 2,719 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
2,719
Total Claims
$2.1M
Total Drug Cost
496
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 6,742.367
- Total Day Supply
- 201,086
- Brand vs Generic
- 61% brand / 32% generic
- Brand Drug Cost
- $2.0M
- Generic Drug Cost
- $14K
Patient Demographics
- Average Patient Age
- 71.6 years
- Avg HCC Risk Score
- 1.66
- Gender Split
- 47% female / 53% male
- Age Distribution
- <65: 54, 65-74: 257, 75-84: 158, 85+: 27
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Michael Goldstein, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Ozempic
Ozempic
258 claims
- Jardiance
Jardiance
245 claims
- Mounjaro
Mounjaro
173 claims
- Atorvastatin Calcium
Atorvastatin Calcium
148 claims
- Lantus Solostar
Lantus Solostar
139 claims
- Metformin Hcl Er
Metformin Hcl Er
134 claims
- Levothyroxine Sodium
Levothyroxine Sodium
122 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
113 claims
| Drug | Claims |
|---|---|
| Ozempic Semaglutide | 258 |
| Jardiance Empagliflozin | 245 |
| Mounjaro Tirzepatide | 173 |
| Atorvastatin Calcium | 148 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 139 |
| Metformin Hcl Er Metformin Hcl | 134 |
| Levothyroxine Sodium | 122 |
| Rosuvastatin Calcium | 113 |
| Trulicity Dulaglutide | 100 |
| Metformin Hcl | 96 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in NY →
All providers in New York →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Michael Goldstein, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider
Michael Goldstein, MD's 2,719 claims are below the specialty average of 2,739.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Goldstein, both outside New York so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2018)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Goldstein.
One of 813 Endocrinology, Diabetes & Metabolism Physician providers enrolled in New York, 5 are shown here.
Dr. Zinoviy Abelev
MD
Long Island City, NY
Dr. Jill Abelseth
M.D.
Albany, NY
Dr. Sherley Abraham
M.D.
New York, NY
Dr. Connor Abramowicz
DO
Port Jefferson, NY
Dr. Jennifer Abrams
DO
Brooklyn, NY
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Michael Goldstein, MD's specialty? ▼
Michael Goldstein, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Mineola, New York. Credentials: MD.
How much does Michael Goldstein, MD prescribe under Medicare Part D? ▼
In 2024, Michael Goldstein, MD wrote 2,719 Medicare Part D claims totaling $2.1M in drug costs for 496 beneficiaries.
Where is Michael Goldstein, MD located? ▼
Michael Goldstein, MD is located at 101 MINEOLA BLVD FL 2, Mineola, NY, 11501. Phone: (516) 663-3511.
What is Michael Goldstein, MD's NPI number? ▼
Michael Goldstein, MD's National Provider Identifier (NPI) is 1124524863, issued on 04/02/2018.
Does Michael Goldstein, MD prescribe more brand-name or generic drugs? ▼
Michael Goldstein, MD's prescribing is 61% brand-name and 32% generic drugs by claim count, with $2.0M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does Michael Goldstein, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Michael Goldstein, MD's most frequently prescribed drugs include Ozempic, Jardiance, Mounjaro. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Michael Goldstein, MD accept Medicare? ▼
Michael Goldstein, MD appears in CMS Medicare data with 2,719 Part D claims and 496 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Michael Goldstein, MD's credentials? ▼
Michael Goldstein, MD's NPI is 1124524863 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.